Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Max Healthcare reported strong FY26 consolidated results with revenue from operations growing 19.1% to ₹8,37,345 lakhs from ₹7,02,846 lakhs in FY25. Profit after tax surged 34.1% to ₹1,44,241 lakhs versus ₹1,07,588 lakhs, driven by operational efficiency and a one-time tax benefit of ₹14,148 lakhs from the completed merger of Crosslay Remedies with Jaypee Healthcare (effective December 15, 2025). Exceptional items of ₹4,824 lakhs included ₹3,390 lakhs towards new Labour Codes impact and ₹1,434 lakhs stamp duty provision. The board recommended a dividend of ₹2 per share and approved construction of a new 712-bed hospital in Lucknow. Auditors issued an unmodified opinion with no qualifications.
The company delivered robust double-digit growth in both revenue and profitability, indicating strong operational execution. The completed merger, new hospital construction, and recent acquisition of Kalinga Hospitals in Bhubaneswar signal expansion plans that could drive future growth. The clean audit opinion with no going concern issues is positive for investor confidence.